Release Date: 12/04/12 14:24 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 729.98KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%